BioNTech and Pfizer to start first COVID-19 vaccine human trial in Germany
German biotechnology company BioNTech is collaborating with Pfizer to develop the BNT162 vaccine programme to prevent COVID-19. The Mainz-based company
Read moreGerman biotechnology company BioNTech is collaborating with Pfizer to develop the BNT162 vaccine programme to prevent COVID-19. The Mainz-based company
Read moreThe U.S. Food and Drug Administration (FDA) has approved a second COVID-19 vaccine developed by Moderna, which will be marketed
Read moreLeading vaccine producers have stated that new vaccines will be developed if necessary to meet the demand of governments worldwide
Read moreThe US Centers for Disease Control and Prevention (CDC) has recommended the use of COVID-19 vaccine boosters for everyone 18
Read moreThe U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) has voted 17 to 0,
Read moreThe US Food and Drug Administration has granted approval for administration of COVID-19 vaccine booster dosage, upgrading the emergency use
Read morePfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced that the FDA’s Vaccines and Related Biological Products Advisory Committee
Read moreAstraZeneca and the European Commission and have reached a settlement on the delivery of pending COVID-19 vaccine doses by the
Read moreThe United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) has authorized use of the Janssen single-dose COVID-19 vaccine. The
Read moreThe announced temporary waiver of COVID-19 vaccine patents by Joe Biden’s administration has hit vaccine maker shares and raised serious
Read more